Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P01350 (
gastrin
)
9,683
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
In dispersed mucosal cells from guinea pig stomach cyclic
AMP
was increased 4-fold by theophylline, 5-fold by prostaglandin E2, and 10- to 15-fold by histamine. Theophylline augmented the increase in cellular cyclic
AMP
caused by histamine or prostaglandin E1 and the actions of histamine and prostaglandin E1 were additive. Cellular cyclic
AMP
was not altered by carbachol,
gastrin
, secretin, vasoactive intestinal peptide, glucagon, insulin or the octapeptide of cholecystokinin. Metiamide or diphenhydramine but not atropine inhibited the increase in cellular cyclic
AMP
caused by histamine, but did not alter the concentration of cyclic
AMP
in control cells or in cells incubated with theophylline or prostaglandin E1.
...
PMID:Cellular cyclic AMP in dispersed mucosal cells from guinea pig stomach. 20 34
The three stimulants of gastric acid secretion likely to have physiological roles in regulation of secretion are acetylcholine,
gastrin
, and histamine. Acetylcholine is released by vagal and intramucosal reflex stimulation, acting directly on the parietal cell.
Gastrin
is released by peptides and free amino acids in the stomach and is the only known hormonal stimulant of acid secretion. Release of
gastrin
by acetylcholine may occur. However, cholinergic control of
gastrin
release is complex since under certain conditions anticholinergic drugs may actually enhance
gastrin
release. Factors regulating histamine release have not been defined, but studies with H2-receptor antagonists leave little doubt that histamine has an important role in acid secretion. Studies with isolated parietal cells indicate that histamine,
gastrin
, and acetylcholine each appear to act at separate receptors on the parietal cell. Anticholinergic agents specifically prevent the cellular actions of acetylcholine, cimetidine specifically inhibits stimulation by histamine, and neither inhibitor blocks the small direct response to
gastrin
. Furthermore potentiating interactions occur between histamine,
gastrin
, and cholinergic agents which may account for the interdependence of secretagogue action observed in vivo. Direct potentiating interactions occur between histamine and
gastrin
and histamine and carbachol but not between carbachol and
gastrin
. However, in the presence of histamine, carbachol, and
gastrin
, a three-way potentiation does occur. By interfering with the potentiating interactions between stimulants, anticholinergic agents and cimetidine display an apparent cross-specificity in vitro that resembles the effects of these agents in intact mucosa. The mechanisms underlying these interactions are unknown, but the actions of histamine appear to be mediated through increased production of cyclic
AMP
and cyclic
AMP
analogs, which mimic the interactions involving histamine itself. The secondary effectors for acetylcholine and
gastrin
and the mechanisms for amplification of the response to combinations of stimulants remain to be elucidated.
...
PMID:Regulation of gastric acid secretion. 21 62
1 An isolated stomach preparation from immature rats has been used to study the role of extracellular calcium in the control of gastric acid secretion. Calcium was removed from both the serosal and mucosal solutions either in the absence of a chelating agent or in the presence of EGTA.2 Removal of calcium in the absence of EGTA had no significant effect on basal acid secretion or the acid responses to
gastrin
and dibutyryl cyclic adenosine 3',5'-monophosphate (db cyclic
AMP
). Under the same conditions there was a marked potentiation of the acid response to histamine, and a reduction of the acid response to acetylcholine which was readily reversed on restoring calcium to the bathing solutions.3 Removal of calcium in the presence of EGTA caused an inhibition of basal acid secretion and of the acid responses to histamine and db cyclic
AMP
. In each case this reduction in acid output was readily reversed on bathing the stomachs in normal calcium-containing (2.5 mM Ca(2+)) EGTA-free solutions.4 The inhibition of the acid response to histamine produced by Ca(2+)-free solutions which contained EGTA was not reversed on bathing the stomachs in solutions that contained both EGTA (0.1 mM) and an excess of calcium (2.5 mM).5 The removal of extracellular calcium in the absence of EGTA provided evidence that the secretion of H(+) ions is dependent under some conditions on calcium ions. The possibility cannot be excluded that EGTA itself exerts an inhibitory influence on the process of acid secretion.
...
PMID:Investigation of the role of extracellular calcium in the control of acid secretion in the isolated whole stomach of the rat. 22 6
Dispersed mucosal cells (approx. 70% parietal cells) prepared from guinea pig stomach maintained their cellular concentration of potassium (65--80 nmol potassium/10(6) cells) for at least 5 h in vitro. Uptake of 42K by dispersed gastric mucosal cells depended on temperature, H+ concentration and oxidative metabolism. Carbachol and, in some instances,
gastrin
caused a 40--50% increase in cellular uptake of 42K as a consequence of the ability of these agents to increase 42K influx. Ouabain reduced uptake of 42K by 70% but did not alter the effect of carbachol. Cellular uptake of 42K was not altered by histamine, prostaglandin, E1, glucagon, secretin, vasoactive intestinal peptide or C-terminal octapeptide of cholecystokinin. Uptake of 42K was also increased by dibutyryl cyclic
AMP
or dibutyryl cyclic GMP but not by cyclic
AMP
, cyclic GMP or their 8-bromo derivatives. Theophylline caused a small (10--15%) increase in 42K uptake and potentiated the increase caused by submaximal concentrations of carbachol. The increase in 42K uptake caused by either dibutyryl cyclic nucleotide and carbachol was additive.
...
PMID:Potassium transport in dispersed mucosal cells from guinea pig stomach. 63 44
The influence of cyclic
AMP
on
gastrin
release from the canine antrum was investigated by a direct in vivo method. After removal of spleen, gastric corpus, pancreas and intestine an antral pouch was consecutively perfused with dibutyryl cyclic
AMP
, papaverin and bethanechol-HCl using a branch of the left gastroepiploic artery. A relevant rise of
gastrin
in portal blood was only observed during perfusion of bethanechol chloride. Thus cyclic
AMP
does not release
gastrin
from the canine antrum.
...
PMID:[Effects of cyclic AMP and urecholine on gastric secretion in the dog]. 120 41
The effects of ethyl alcohol, 20%, were measured on steady state rates of ion transport by isolated mucosa. Luminal, but not serosal, addition of alcohol altered ion transport. Alcohol caused a sustained reduction in apparent basal acid secretion by fundic mucosa. These tissues were resistant to ordinarily effective stimulants of acid secretion (histamine, theophyline, dibutyryl cyclic
AMP
, and
gastrin
) by rabbit mucosa. Across antral mucosa, net Na transport was inhibited, and net Cl transport was reduced in the presence of alcohol. The unidirectional fluxes of both ions were increased as was permeability to erythritol. These effects of alcohol did not require the presence of acid in the lumen. The rate of luminal acid loss by antrum was increased by alcohol. Addition of ouabain alone, which inhibits net Na and Cl transport, did not alter the rate of luminal acid loss by antrum. Alcohol, however, still increased the rate of luminal acid loss by antral mucosa treated with ouabain. Alcohol reduced the electrical resistance of fundic and antral mucosa but had no effect on the rate of luminal acid loss or electrical resistance of esophageal mucosa. Luminal application of alcohol inhibits active ion transport in addition to increasing cation and anion permeability. However, inhibition of active transport per se is not necessarily associated with an increase in mucosal permeability.
...
PMID:Effects of alcohol on ion transport by isolated gastric and esophageal mucosa. 124 81
In antrectomized (B-I) and control rats, bone mineralization, the fractional intestinal absorption of calcium, magnesium and phosphorus, the balances of these minerals, their serum concentration and renal excretion, together with serum
gastrin
, calciotropic hormones (parathyroid hormone, calcitonin, 1,25-dihydroxyvitamin D), and osteocalcin were assessed four months after surgery. B-I evoked hypogastrinemia, but no changes in the serum concentrations of minerals and calciotropic hormones, or urinary cyclic
AMP
. The major significant changes brought about by B-I were: (1) a decrease in bone dry weight, specific density, bone ash calcium and magnesium content; (2) a decrease in the fractional absorption and urinary excretion of calcium and magnesium; (3) an increase in urinary hydroxyproline and serum osteocalcin in the presence of normal serum bone isoenzyme of alkaline phosphatase. It is concluded that in the rat (1) B-I over the long term decreases both bone mineral content and calcium and magnesium absorption, in the absence of any counterregulation; (2) B-I rats may have attained a new equilibrium which is characterized by decreased absorption and urinary excretion of calcium and magnesium, but maintenance of normocalcemia at the expense of bone; (3) the concomitant changes of serum bone markers are contradictory, which makes their interpretation and use in the present context difficult.
...
PMID:Disturbances of mineral and bone metabolism following gastric antrectomy in the rat. 133 20
These studies were performed to determine the intracellular pathways involved in regulating
gastrin
gene expression. The inclusion of 10(-4) M forskolin or 10(-4) M dibutyryl cyclic
AMP
(DBcAMP) in incubation medium containing dog antral mucosa resulted in 249% and 323% increases, respectively, in
gastrin
mRNA levels. The stimulatory effects of forskolin and DBcAMP were both inhibited significantly by 10(-6) M somatostatin. Preincubation of antral mucosa with pertussis toxin nearly abolished the inhibitory effects of somatostatin on
gastrin
mRNA stimulated by forskolin, but had no effect following DBcAMP. To examine whether calcium-dependent pathways might be involved in regulating
gastrin
gene expression, antral mucosa was incubated with increasing concentrations of calcium or the ionophore ionomycin. Both agents produced only modest increases in
gastrin
mRNA, which were abolished by the addition of somatostatin to the incubation medium. These studies indicate that somatostatin appears to inhibit
gastrin
gene expression through mechanisms involving both pertussis toxin-sensitive and -insensitive pathways.
...
PMID:Somatostatin inhibition of gastrin gene expression: involvement of pertussis toxin-sensitive and -insensitive pathways. 135 Mar 57
Two novel neuromedin C analogs [D-Ala1, Leu9-psi-CH2NH-Leu10]neuromedin C and [Leu9-psi-CH2NH-Leu10]neuromedin C, were synthesized by rapid solid phase methods and examined for their abilities to inhibit neuromedin C-stimulated amylase release by isolated rat pancreatic acini. Both analogs significantly inhibited maximally stimulated amylase release by neuromedin C in a dose-dependent manner with maximal inhibition seen at concentrations of 100 and 300 microM of [D-Ala1, Leu9-psi-CH2NH-Leu10]neuromedin C and [Leu9-psi-CH2NH-Leu10]neuromedin C, respectively. The IC50 (concentration required to half-maximally inhibit neuromedin C-stimulated amylase release) was 1.5 microM for [D-Ala1, Leu9-psi-CH2NH-Leu10]neuromedin C compared to a 13.4 microM IC50 for [Leu9-psi-CH2NH-Leu10]neuromedin C. The [D-Ala1, Leu9-psi-CH2NH-Leu10]neuromedin C analog produced a parallel rightward shift in the neuromedin C dose-response curve and Schild plots of the inhibition data gave a slope of 0.969 +/- 0.121 and a pA2 (apparent affinity for the acinar cell receptor in terms of neuromedin C receptor-stimulated amylase release) of 100 nM. While [D-Ala1, Leu9-psi-CH2NH-Leu10]neuromedin C significantly inhibited both neuromedin B- and
gastrin
releasing peptide-stimulated amylase release, the analog did not inhibit amylase release in response to either cholecystokinin octapeptide, vasoactive intestinal peptide, substance P, carbamylcholine, the Ca2+ ionophore A23187, forskolin, or 8-bromo-cyclic
AMP
. The results demonstrate that [D-Ala1, Leu9-psi-CH2NH-Leu10]neuromedin C is a potent, specific, and competitive antagonist for neuromedin C and peptides of the
gastrin
releasing peptide family and may serve as a useful molecule for exploring the physiological role of these peptides.
...
PMID:[D-Ala1, Leu9-psi-CH2NH-Leu10]neuromedin C antagonizes neuromedin C-stimulated amylase release by acini isolated from the rat pancreas. 169 79
In recent years, the localization and physiological significance of vasoactive intestinal peptide (VIP) in various organs have been studied. Investigations of the significance of VIP in the ovary have been done, but the detailed mechanism of action is still unknown. We made in vitro studies of VIP using rat ovaries. Ovarian granulosa cells were collected after treatment with estrogen in immature hypophysectomized rats. Luteal cells were collected from immature rats treated with pregnant mare serum (PMS) and human chorionic gonadotropin (hCG). These cells were cultured in a serum free medium for 48 hr in the absence or presence of various amounts of VIP. We determined the amount of steroids produced in the culture medium by specific RIA. Activities of 3 beta-HSD in the granulosa cells were determined by the amount of progesterone formed from labelled pregnenolone. Induction of LH-receptor in the granulosa cells by VIP and VIP-receptor in these cells was investigated. VIP stimulated estrogen and progesterone production dose and time dependently with an approximate ED50 value of 3 x 10(-8) M. The amount of cyclic adenosine monophosphate (c-AMP) was similarly increased. VIP enhanced 3 beta-hydroxysteroid dehydrogenase (3 beta-HSD) activity when incubated with the granulosa cells for 24 hours. VIP stimulated the granulosa cells in a way similar to follicle stimulating hormone (FSH), but the stimulating effect was slightly less than that of FSH. Unlike FSH, VIP did not induce LH-receptor. The binding of 125I-VIP with the granulosa cells was blocked, dose dependently, by unlabelled VIP, suggesting the presence of VIP-receptor in the granulosa cells. Another peptide, PHM-27, stimulated the granulosa cells although its potency was less than that of VIP. In contrast,
gastrin
, CCK and secretion did not stimulate the granulosa cells at all. According to the present study. VIP did not exert any effect on the luteal cells, and progesterone production in vitro was not stimulated by this peptide. The VIP effects seem to be at least partly c-
AMP
dependent and may be mediated through the VIP-receptor in the granulosa cells. The observed direct effects of VIP suggest that it may act as a local hormone to regulate the ovarian function.
...
PMID:[The effect of vasoactive intestinal peptide on the rat ovary]. 217 Feb 9
<< Previous
1
2
3
4
5
6
7
8
Next >>